BLISSGVS

Bliss Gvs Pharma Share Price Bliss GVS Pharma

₹112.85
-1.2 (-1.05%)
28 March, 2024 20:13 BSE: 506197 NSE: BLISSGVSISIN: INE416D01022

Start SIP in Bliss GVS Pharma

Start SIP

Bliss Gvs Pharma Performance

Day Range

  • Low 112
  • High 117
₹ 112

52 Week Range

  • Low 69
  • High 150
₹ 112
  • Open Price116
  • Previous Close114
  • Volume367160

Bliss Gvs Pharma Share Price

  • Over 1 Month -8.55%
  • Over 3 Month -10.54%
  • Over 6 Month 27.3%
  • Over 1 Year 58.39%

Bliss Gvs Pharma Key Statistics

P/E Ratio 13.4
PEG Ratio 14.7
Market Cap Cr 1,181
Price to Book Ratio 1.3
EPS 8.1
Dividend 0.4
Relative Strength Index 47.23
Money Flow Index 52.77
MACD Signal -3.19
Average True Range 7.13
Bliss GVS Pharma Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 161171109143
Operating Expenses Qtr Cr 13312998133
Operating Profit Qtr Cr 29421111
Depreciation Qtr Cr 6654
Interest Qtr Cr 2115
Tax Qtr Cr 81232
Net Profit Qtr Cr 213476
IndicatorMar 2023
Total Revenue Annual Cr 649
Operating Expenses Annual Cr 508
Operating Profit Annual in Cr 90
Depreciation Cr 15
Interest Annual Cr 10
Tax Annual Cr 30
Net Profit Annual Cr 85
IndicatorMar 2023
Cash from Operating Activity Annual Cr 44
Cash from Investing Activity Annual Cr -13
Cash from Financing Annual Activity Cr -26
Net Cash Flow Annual Cr 5
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 937
Fixed Assets Annual Cr 328
Total Non Current Assets Annual Cr 410
Total Current Assets Annual Cr 730
Total Assets Annual Cr 1,140
IndicatorMar 2023
Book Value Per Share Annual Rs 90
ROE Annual % 9
ROCE Annual % 13
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 24
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 201212160185
Operating Expenses Qtr Cr 157158135179
Operating Profit Qtr Cr 4454246
Depreciation Qtr Cr 7665
Interest Qtr Cr 2115
Tax Qtr Cr 11167-4
Net Profit Qtr Cr 2842153
IndicatorMar 2023
Total Revenue Annual Cr 769
Operating Expenses Annual Cr 634
Operating Profit Annual in Cr 117
Depreciation Cr 19
Interest Annual Cr 10
Tax Annual Cr 29
Net Profit Annual Cr 71
IndicatorMar 2023
Cash from Operating Activity Annual Cr 34
Cash from Investing Activity Annual Cr -8
Cash from Financing Annual Activity Cr -25
Net Cash Flow Annual Cr 2
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 884
Fixed Assets Annual Cr 374
Total Non Current Assets Annual Cr 459
Total Current Assets Annual Cr 697
Total Assets Annual Cr 1,157
IndicatorMar 2023
Book Value Per Share Annual Rs 88
ROE Annual % 8
ROCE Annual % 12
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 18

Bliss Gvs Pharma Technicals

EMA & SMA

Current Price
₹112.85
-1.2 (-1.05%)
pointer
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • ₹114.11
  • 50 Day
  • ₹117.74
  • 100 Day
  • ₹116.49
  • 200 Day
  • ₹108.76
  • 20 Day
  • ₹114.24
  • 50 Day
  • ₹118.73
  • 100 Day
  • ₹123.99
  • 200 Day
  • ₹106.94

Bliss Gvs Pharma Resistance and Support

PIVOT
₹113.7
Resistance
First Resistance 115.85
Second Resistance 118.85
Third Resistance 121.00
RSI 47.23
MFI 52.77
MACD Single Line -3.19
MACD -2.73
Support
First Resistance 110.70
Second Resistance 108.55
Third Resistance 105.55

Bliss Gvs Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 406,848 20,069,812 49.33
Week 504,226 23,133,877 45.88
1 Month 646,143 26,556,460 41.1
6 Month 946,179 40,042,288 42.32

Bliss Gvs Pharma Result Highlights

Bliss GVS Pharma Synopsis

NSE-Medical-Generic Drugs

Bliss Gvs Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 598.34 Cr. and Equity Capital is Rs. 10.42 Cr. for the Year ended 31/03/2023. Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771.
Market Cap 1,176
Sales 585
Shares in Float 6.80
No of funds 30
Yield 0.44
Book Value 1.25
U/D Vol ratio 1.1
LTDebt / Equity 4
Alpha
Beta 1.68

Bliss GVS Pharma

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 34.97%35.06%35.12%35.04%
Mutual Funds
Insurance Companies 6.59%6.61%6.62%6.63%
Foreign Portfolio Investors 15.35%16.31%16.5%16.6%
Individual Investors 30.78%29.17%30.1%30.01%
Others 12.31%12.85%11.66%11.72%

Bliss GVS Pharma Management

Name Designation
Mr. S R Vaidya Chairman & Ind.Director
Mr. Gagan Harsh Sharma Managing Director
Dr. Vibha Gagan Sharma Whole Time Director
Mrs. Shruti Vishal Rao Whole Time Director
Mr. Santosh L Parab Independent Director
Mrs. Shilpa Bhatia Independent Woman Director

Bliss Gvs Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Bliss Gvs Pharma Corporate Action

Date Purpose Remarks
2024-01-23 Quarterly Results
2023-11-01 Quarterly Results
2023-08-01 Quarterly Results
2023-05-11 Audited Results & Final Dividend
2023-01-24 Quarterly Results

Bliss GVS Pharma MF Shareholding

Name Amount(cr)

Bliss GVS Pharma FAQs

What is Share Price of Bliss GVS Pharma ?

Bliss GVS Pharma share price is ₹112 As on 28 March, 2024 | 19:59

What is the Market Cap of Bliss GVS Pharma ?

The Market Cap of Bliss GVS Pharma is ₹1181.4 Cr As on 28 March, 2024 | 19:59

What is the P/E ratio of Bliss GVS Pharma ?

The P/E ratio of Bliss GVS Pharma is 13.4 As on 28 March, 2024 | 19:59

What is the PB ratio of Bliss GVS Pharma ?

The PB ratio of Bliss GVS Pharma is 1.3 As on 28 March, 2024 | 19:59

Q2FY23